[24] Likewise, dinaciclib demonstrated remarkable cytotoxicity in CLL and in vivo inhibition of Mcl-1 expression and PARP cleavage in acute myeloid leukemia patients. The gene discussed is MCL1; the disease is B-cell chronic lymphocytic leukemia.